American Heart Association

New drugs slash bad cholesterol


Editor’s note: This is one in a 10-part series of the top medical research advances in 2015 as determined by American Heart Association volunteer and staff leaders.

The blockbuster drugs known as statins are teaming with a new medication to lower the level of bad LDL […]

Powerful cholesterol drug awaits FDA’s decision


A second in a new class of drugs that sharply lowers cholesterol is set for federal approval by Thursday – a “game-changer” for the hardest-to-treat patients who are in danger of heart attacks and strokes.

For people with familial hypercholesterolemia, or FH, a genetic condition that […]

August 26th, 2015|Categories: Blog|Tags: , , , |0 Comments

FDA approves new cholesterol drug


For the first time in decades, the U.S. Food and Drug Administration on Friday approved a major new class of medicines to lower cholesterol, and thereby protect against heart attacks.

Praluent (alirocumab) from Sanofi and Regeneron Pharmaceuticals received approval and a second drug, Repatha (evolocumab) from […]

July 24th, 2015|Categories: Blog|Tags: , , |4 Comments

More college-age kids would take statins under pediatric guidelines


For children and adults with elevated levels of “bad” cholesterol, guidelines are available to point physicians to the most appropriate treatment. But for patients who are no longer children but not quite yet adults, knowing which recommendations to follow hasn’t been clear-cut.

Now, a new study […]

April 6th, 2015|Categories: Blog|Tags: , , |0 Comments

STORIES FROM THE HEART: Gospel singer’s new tune praises importance of being heart healthy


Gospel singer LaJaye’ Britt always kept one foot in the music world and another in the medical field.

Whether performing on stage or working as a technician with dialysis and cardiac patients, Britt was totally in tune with others. Then, one day last May, it was time […]

After one year, patients on new drug fare better than standard therapy

Patients taking evolocumab—an investigational therapy previously shown to dramatically lower “bad” cholesterol—were half as likely to die, suffer a heart attack or stroke, be hospitalized or need a procedure to open blocked arteries compared with those who received standard care, according to research presented at the American College of […]

Poor response to cholesterol drugs may indicate blocked arteries

If your “bad” cholesterol level stays the same or increases after you take statin drugs, you may have more blocked arteries than people whose levels drop, according to research in the American Heart Association journal Arteriosclerosis, Thrombosis and Vascular Biology.

Low density lipoprotein cholesterol is considered the “bad” cholesterol because […]

February 26th, 2015|Categories: Blog|Tags: , , , |2 Comments

High cholesterol during young adulthood raises heart disease risk

New research in the American Heart Association’s journal Circulation shows that long-term exposure to elevated cholesterol substantially increases lifetime risk for heart disease. For every ten years you have even mildly elevated cholesterol between the ages of 35 and 55, your risk of heart disease may be increased by […]

January 26th, 2015|Categories: Blog|Tags: , , , |5 Comments

STORIES FROM THE HEART: Amazing series of events helped Gene beat the odds – again

Realtor Gene Cragoe was driving to his office to check something when he started to “get real dizzy, real quick.”

He took his foot off the accelerator and tried guiding his van off the highway in the small town of Luverne, Minnesota. Unfortunately, there was no shoulder on the main […]

Low-cost vaccine lowers bad cholesterol in animal studies

A low-cost vaccine safely lowered levels of bad cholesterol in animal studies — raising the possibility for an easier and more accessible way to control cholesterol in humans, according to research presented at the American Heart Association’s Scientific Sessions 2014.

The vaccine targets PCSK9, an enzyme that degrades a receptor […]